CN1756542A - L－多巴、其衍生物和含有该化合物的药物用于预防精神疾病的用途 - Google Patents

L－多巴、其衍生物和含有该化合物的药物用于预防精神疾病的用途 Download PDF

Info

Publication number
CN1756542A
CN1756542A CNA2003801066148A CN200380106614A CN1756542A CN 1756542 A CN1756542 A CN 1756542A CN A2003801066148 A CNA2003801066148 A CN A2003801066148A CN 200380106614 A CN200380106614 A CN 200380106614A CN 1756542 A CN1756542 A CN 1756542A
Authority
CN
China
Prior art keywords
dopa
physiological compatibility
tyrosine
inhibitor
derivant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2003801066148A
Other languages
English (en)
Chinese (zh)
Inventor
R-G·阿尔肯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BDD Berolina Drug Development GmbH
Original Assignee
BDD Berolina Drug Development GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BDD Berolina Drug Development GmbH filed Critical BDD Berolina Drug Development GmbH
Publication of CN1756542A publication Critical patent/CN1756542A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2003801066148A 2002-12-19 2003-12-18 L－多巴、其衍生物和含有该化合物的药物用于预防精神疾病的用途 Pending CN1756542A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10261808.9 2002-12-19
DE10261808A DE10261808A1 (de) 2002-12-19 2002-12-19 Verwendung von L-DOPA, seiner Derivate und diese Verbindungen enthaltender Arzneimittel zur Prophylaxe psychotischer Erkrankungen

Publications (1)

Publication Number Publication Date
CN1756542A true CN1756542A (zh) 2006-04-05

Family

ID=32478131

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2003801066148A Pending CN1756542A (zh) 2002-12-19 2003-12-18 L－多巴、其衍生物和含有该化合物的药物用于预防精神疾病的用途

Country Status (10)

Country Link
EP (1) EP1615631A2 (fr)
JP (1) JP2006511558A (fr)
CN (1) CN1756542A (fr)
AU (1) AU2003294664A1 (fr)
CA (1) CA2513077A1 (fr)
DE (1) DE10261808A1 (fr)
EA (1) EA200500957A1 (fr)
MX (1) MXPA05006409A (fr)
PL (1) PL377524A1 (fr)
WO (1) WO2004056306A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105078952A (zh) * 2015-08-10 2015-11-25 中国康复研究中心 一种左旋多巴制剂及其应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401842D0 (sv) 2004-07-12 2004-07-12 Dizlin Medical Design Ab Infusion and injection solution of levodopa
CA2642593C (fr) * 2006-02-17 2014-11-04 Birds Pharma Gmbh Berolina Innovative Research & Development Services Derives de catecholamine deuteries et medicaments comprenant de tels composes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102431A (en) * 1976-02-25 1977-08-27 Kyowa Hakko Kogyo Co Ltd Remedies for mental disorder
CA1161451A (fr) * 1977-07-01 1984-01-31 Brian W. Metcalf ACIDES AMINES .alpha.-ACETYLENIQUES
US5149786A (en) * 1989-10-12 1992-09-22 Chiron Corporation Dopamine releasing protein and antibody

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105078952A (zh) * 2015-08-10 2015-11-25 中国康复研究中心 一种左旋多巴制剂及其应用

Also Published As

Publication number Publication date
JP2006511558A (ja) 2006-04-06
CA2513077A1 (fr) 2004-07-08
EA200500957A1 (ru) 2006-02-24
EP1615631A2 (fr) 2006-01-18
WO2004056306A3 (fr) 2004-11-11
MXPA05006409A (es) 2006-05-31
WO2004056306A2 (fr) 2004-07-08
DE10261808A1 (de) 2004-07-08
AU2003294664A1 (en) 2004-07-14
PL377524A1 (pl) 2006-02-06

Similar Documents

Publication Publication Date Title
JP5248331B2 (ja) 重水素化カテコールアミン誘導体およびその化合物を含む薬剤
US20030130355A1 (en) Therapeutic agents
JP2003521470A5 (fr)
JP2018193356A (ja) 重水素化カテコールアミン誘導体ならびにそれらの化合物を含有する医薬品
TWI589305B (zh) 用於經口投藥之包含安布索、左旋羥丙哌嗪及緩衝劑的液體調配物以及製備其之方法
EP2474309A1 (fr) Composition pharmaceutique à base d&#39;ibuprofène, de tramadol et d&#39;un aminoacide basique, procedé pour sa préparation et utilisation de cette dernière
CN111635315B (zh) 一种解热镇痛药物及其制备方法和用途
CN104013638B (zh) 当药黄素及其衍生物的用途
HUP0400213A2 (hu) Deuterált N- és alfa-helyettesített difenil-alkoxi-ecetsav-(amino-alkil)-észterek, valamint az ezen vegyületeket tartalmazó gyógyszerkészítmények
JP6704252B2 (ja) 位置特異的非対称重水素富化カテコールアミン誘導体および前記化合物を含有する医薬
CN101088498A (zh) 补骨脂酚类化合物的应用
KR101816953B1 (ko) １-[２-(２,４-디메틸-페닐술파닐)페닐]-피페라진의 치료적 용도
CN102186480A (zh) 包含6-二甲基氨基甲基-1-(3-甲氧基-苯基)-环己烷-1，3-二醇和非甾体抗炎药的药物合剂
CN101808646A (zh) 用于改善帕金森氏病的运动并发症或精神症状的药剂
CN1756542A (zh) L－多巴、其衍生物和含有该化合物的药物用于预防精神疾病的用途
AU5446401A (en) Agent for treating parkinson&#39;s disease comprising astrocyte function-improving agent as active ingredient
US20070082953A1 (en) Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases
KR20160146689A (ko) 파킨슨병을 치료하기 위한 도파민 효능제 및 l-dopa 유도체를 포함하는 조성물
HK1087029A (en) Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases
CN105530929B (zh) 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途
HK40067137A (en) Combination of ibuprofen and tramadol for relieving pain
JPH07215873A (ja) 強心剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1087029

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1087029

Country of ref document: HK